Notably, the KRAS-specific DARPin fused to VHL effectively inhibited the proliferation of RAS-driven cancer cell lines with minimal effects on selected WT-KRAS cell lines26, suggesting the potential utility of KRAS-selective but not mutant-selective degraders. Here, VHL is linked to cancer.